CERENO SCIENTIFIC AB (PUBL) Cereno Scientific AB (publ) Stock NORDIC GROWTH MARKET
Equities
CRNO B
SE0008241558
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.521 SEK | -7.13% |
|
+7.98% | -76.90% |
| Jul. 10 | Cereno Scientific Extends Financial Runway by Extending Loan Maturity Date | CI |
| Jul. 09 | Cereno Scientific Secures New Patents for Hypertension Drug Candidate | MT |
| Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.88B 179M |
|---|---|---|---|---|---|
| Net income 2024 * | -49M -4.66M | Net income 2025 * | -47M -4.47M | EV / Sales 2024 * | - |
| Net cash position 2024 * | 11.74M 1.12M | Net cash position 2025 * | 145M 13.78M | EV / Sales 2025 * | - |
| P/E ratio 2024 * |
-37.2
x | P/E ratio 2025 * |
-39.4
x | Employees | - |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.01% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -7.13% |
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 15-08-31 | |
Eva Jagenheim
DFI | Director of Finance/CFO | 58 | 23-08-27 |
Fredrik Frick
CTO | Chief Tech/Sci/R&D Officer | 51 | 22-04-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Tech/Sci/R&D Officer | 71 | 12-04-11 | |
| Director/Board Member | 71 | - | |
| Director/Board Member | 47 | 12-04-11 |
Cereno Scientific AB is a manufacturer of pharmaceutical preparation. The Company was founded in 1970 and is located in Gothenburg, Sweden.
Calendar
2024-08-28
- Q2 2024 Earnings Release
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +20.12% | 126B | |
| +25.25% | 119B | |
| +25.56% | 27.95B | |
| -19.51% | 20.5B | |
| -14.36% | 17.12B | |
| -15.63% | 16.1B | |
| -46.67% | 14.97B | |
| +11.89% | 14.84B | |
| +57.74% | 14.38B |
- Stock Market
- Equities
- CRNO B Stock
- CRNO B Stock
